(en) Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J, « Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. », Metabolism, vol. 28, 1,979, p. 1086-1096 (PMID386029, DOI10.1016 / 0026-0495 (79) 90146-X, résumé)
(en) Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, « Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. », Diabetologia, vol. 28, no 7, , p. 412–9 (PMID3899825, DOI10.1007/BF00280883)
(en) A. S. Rudenski, D. R. Matthews, J. C. Levy et R. C. Turner, « Understanding insulin resistance: Both glucose resistance and insulin resistance are required to model human diabetes », Metabolism, vol. 40, no 9, , p. 908–917 (ISSN0026-0495, PMID1895955, DOI10.1016/0026-0495(91)90065-5)
(en) Levy JC, Matthews DR, Hermans MP, « Correct homeostasis model assessment (HOMA) evaluation uses the computer program », Diabetes Care, vol. 21, no 12, , p. 2191–2 (PMID9839117, DOI10.2337/diacare.21.12.2191)
(en) Hermans MP, Levy JC, Morris RJ, Turner RC, « Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes », Diabetes, vol. 48, no 9, , p. 1779–86. (PMID10480608, DOI10.2337/diabetes.48.9.1779)
(en) Hermans MP, Levy JC, Morris RJ, Turner RC, « Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes », Diabetologia, vol. 42, no 6, , p. 678–87 (PMID10382587, DOI10.1007/s001250051215)
(en) Hill NR, Levy JC, Matthews DR, « Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2 », Diabetes Care, vol. 36, no 8, , p. 2324-30 (PMID23564921, DOI10.2337/dc12-0607, résumé)
(en) A. S. Rudenski, D. R. Matthews, J. C. Levy et R. C. Turner, « Understanding insulin resistance: Both glucose resistance and insulin resistance are required to model human diabetes », Metabolism, vol. 40, no 9, , p. 908–917 (ISSN0026-0495, PMID1895955, DOI10.1016/0026-0495(91)90065-5)
(en) Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J, « Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. », Metabolism, vol. 28, 1,979, p. 1086-1096 (PMID386029, DOI10.1016 / 0026-0495 (79) 90146-X, résumé)
(en) Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, « Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. », Diabetologia, vol. 28, no 7, , p. 412–9 (PMID3899825, DOI10.1007/BF00280883)
(en) A. S. Rudenski, D. R. Matthews, J. C. Levy et R. C. Turner, « Understanding insulin resistance: Both glucose resistance and insulin resistance are required to model human diabetes », Metabolism, vol. 40, no 9, , p. 908–917 (ISSN0026-0495, PMID1895955, DOI10.1016/0026-0495(91)90065-5)
(en) Levy JC, Matthews DR, Hermans MP, « Correct homeostasis model assessment (HOMA) evaluation uses the computer program », Diabetes Care, vol. 21, no 12, , p. 2191–2 (PMID9839117, DOI10.2337/diacare.21.12.2191)
(en) Hermans MP, Levy JC, Morris RJ, Turner RC, « Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes », Diabetes, vol. 48, no 9, , p. 1779–86. (PMID10480608, DOI10.2337/diabetes.48.9.1779)
(en) Hermans MP, Levy JC, Morris RJ, Turner RC, « Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes », Diabetologia, vol. 42, no 6, , p. 678–87 (PMID10382587, DOI10.1007/s001250051215)
(en) Hill NR, Levy JC, Matthews DR, « Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2 », Diabetes Care, vol. 36, no 8, , p. 2324-30 (PMID23564921, DOI10.2337/dc12-0607, résumé)